AR011907A1 - UTILIZACIoN DEL ACIDO 4-(2,2-DIMETILPROPANOL)BUTANOICO (PIVAGABIN)PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE FORMAS DE ANSIEDADDEPRESIVA. - Google Patents
UTILIZACIoN DEL ACIDO 4-(2,2-DIMETILPROPANOL)BUTANOICO (PIVAGABIN)PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE FORMAS DE ANSIEDADDEPRESIVA.Info
- Publication number
- AR011907A1 AR011907A1 ARP980100917A ARP980100917A AR011907A1 AR 011907 A1 AR011907 A1 AR 011907A1 AR P980100917 A ARP980100917 A AR P980100917A AR P980100917 A ARP980100917 A AR P980100917A AR 011907 A1 AR011907 A1 AR 011907A1
- Authority
- AR
- Argentina
- Prior art keywords
- forms
- dimethylpropanol
- prepare
- treatment
- pharmaceutical composition
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 3
- 230000003001 depressive effect Effects 0.000 title abstract 3
- 230000036506 anxiety Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- SRPNQDXRVRCTNK-UHFFFAOYSA-N pivagabine Chemical compound CC(C)(C)C(=O)NCCCC(O)=O SRPNQDXRVRCTNK-UHFFFAOYSA-N 0.000 title 1
- 229960003084 pivagabine Drugs 0.000 title 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 230000006978 adaptation Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Utilizacion del ácido 4-(2,2-dimetilpropanol)butanoico para preparar una composicion farmacéutica para el tratamiento de formas de ansiedad depresiva.Entre las formas depresivas se pueden indicar las siguientes alteraciones del estado de ánimo,transtornos de ansiedad, transtornos somatoformes ytranstornos de adaptacion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI000456A IT1290003B1 (it) | 1997-03-03 | 1997-03-03 | Uso di pivagabina per preparare composizioni farmaceutiche |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011907A1 true AR011907A1 (es) | 2000-09-13 |
Family
ID=11376246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100917A AR011907A1 (es) | 1997-03-03 | 1998-03-02 | UTILIZACIoN DEL ACIDO 4-(2,2-DIMETILPROPANOL)BUTANOICO (PIVAGABIN)PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE FORMAS DE ANSIEDADDEPRESIVA. |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2001513800A (es) |
| AR (1) | AR011907A1 (es) |
| AU (1) | AU7031798A (es) |
| IL (1) | IL131355A0 (es) |
| IT (1) | IT1290003B1 (es) |
| WO (1) | WO1998038988A1 (es) |
| ZA (1) | ZA981729B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR031473A1 (es) * | 2000-11-20 | 2003-09-24 | Lundbeck & Co As H | Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide |
| US7632836B2 (en) * | 2006-11-30 | 2009-12-15 | Cenerx Biopharma, Inc. | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| EP3441382B1 (en) * | 2016-04-05 | 2023-08-30 | Moresco Corporation | Oxa acid compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1202402B (it) * | 1977-06-01 | 1989-02-09 | Galzigna Lauro | Derivati idrofobici dell'acido 4-aminobutirrico |
-
1997
- 1997-03-03 IT IT97MI000456A patent/IT1290003B1/it active IP Right Grant
-
1998
- 1998-02-25 IL IL13135598A patent/IL131355A0/xx unknown
- 1998-02-25 AU AU70317/98A patent/AU7031798A/en not_active Abandoned
- 1998-02-25 JP JP53816898A patent/JP2001513800A/ja active Pending
- 1998-02-25 WO PCT/EP1998/001279 patent/WO1998038988A1/en not_active Ceased
- 1998-03-02 AR ARP980100917A patent/AR011907A1/es unknown
- 1998-03-02 ZA ZA981729A patent/ZA981729B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI970456A1 (it) | 1998-09-03 |
| ZA981729B (en) | 1998-08-28 |
| IT1290003B1 (it) | 1998-10-19 |
| IL131355A0 (en) | 2001-01-28 |
| WO1998038988A1 (en) | 1998-09-11 |
| JP2001513800A (ja) | 2001-09-04 |
| AU7031798A (en) | 1998-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05419B1 (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| ES2165878T3 (es) | Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central. | |
| ATE320184T1 (de) | Xylitolzusammensetzungen zur behandlung der oberen atmungsorgane | |
| ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
| ES2181614T3 (es) | Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. | |
| EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| AR029825A1 (es) | Una composicion farmaceuticamente aceptable que comprende carvedilol o una sal del mismo farmaceuticamente aceptable, un procedimiento para la produccion de dicha composicion y utilizacion de la misma | |
| ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
| DK1294353T3 (da) | Anvendelse af en (R) -enantiomer af liponsyre i kosmetiske og dermatologiske sammensætninger | |
| SE9701161D0 (sv) | New use I | |
| AR012193A1 (es) | Nuevas combinaciones terapeuticas | |
| DK1315506T3 (da) | Phospholipidderivater af valproinsyre og blandinger deraf | |
| ES2150808T3 (es) | Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico. | |
| AR020660A1 (es) | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz | |
| EE05357B1 (et) | Tablett, mis sisaldab vhemalt kahte eristatavat segmenti, ning selle kasutamine | |
| ES2111175T3 (es) | Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias. | |
| MX9701996A (es) | Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno. | |
| ES2064082T3 (es) | Proteinas bcrf1 como inhibidores de interferon-gamma. | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| AR011907A1 (es) | UTILIZACIoN DEL ACIDO 4-(2,2-DIMETILPROPANOL)BUTANOICO (PIVAGABIN)PARA PREPARAR UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE FORMAS DE ANSIEDADDEPRESIVA. | |
| ES2170390T3 (es) | Fluorenonas alquiloxiamino-substituidas y su uso como inhibidores de la proteina kinasa-c. | |
| ES2125356T3 (es) | Empleo de leflunomida para la inhibicion de interleuquina 8. | |
| ES2163220T3 (es) | Dioxacicloalcan-8-ona. | |
| AR021965A1 (es) | Utilizacion de inhibidores del intercambiador sodio-hidrogeno para la preparacion de un medicamento para la prevencion de la disfuncion de los organosrelacionada con la edad, de las enfermedades relacionadas con la edad y para la prolongacion de la vida |